Director of Simmons Cancer Center and UTSW Pharmacology Chair Elected to the NAM
(left) Carlos L. Arteaga, M.D., Director of the Harold C. Simmons Comprehensive Cancer Center; (right) David Mangelsdorf, Ph.D., Chair and Professor of Pharmacology Carlos L. Arteaga, M.D., Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern, and David Mangelsdorf, Ph.D., Chair of Pharmacology and Professor of Biochemistry, have been elected to the National Academy of Medicine (NAM), one of the highest honors in health and medicine. Dr. Arteaga, also a Professor of Internal Medicine, is recognized for breakthroughs in breast cancer research, including the development of PI3K inhibitors to slow cancer progression. Dr. Mangelsdorf's work in lipid biology has paved the way for potential treatments for diabetes, obesity, cancer, parasitic infections, and more.
Director of Simmons Cancer Center and UTSW Pharmacology Chair Elected to the NAM
